A critical discovery in cancer research is arising with the use of nanobodies to re-engage damaged p53. This vital malignant inhibitor protein is frequently disabled in various types of tumors, leading uncontrolled https://socialstrategie.com/story7738760/vhh-fragments-reactivate-the-p53-protein-a-promising-pathway-for-tumor-treatment